Results 161 to 170 of about 7,191 (206)

ABCA4 mediated traumatic proliferative vitreoretinopathy associated with PI3K/Akt signaling pathway. [PDF]

Heliyon
Menghua W, Hu Z.
europepmc   +1 more source

Vitreous Olink proteomics reveals inflammatory biomarkers for diagnosis and prognosis of traumatic proliferative vitreoretinopathy. [PDF]

Front Immunol
Guo H, Wang T, Yu J, Shi Z, Liang M, Chen S, He T, Yan H.   +7 more
europepmc   +1 more source

Effect of Oral Prednisone on the Prevention and Management of Proliferative Vitreoretinopathy After Open-Globe Injury. [PDF]

J Vitreoretin Dis
Yao T, Chauhan MZ, Uwaydat SH.
europepmc   +1 more source

The Wisconsin silicone oil study (report #1): anatomical and functional outcomes of repair of retinal detachment with proliferative vitreoretinopathy. [PDF]

Eye (Lond)
Schildroth KR, Wingelaar MJ, Boeke PS, Ip MS, Chang JS, Gottlieb JL, Nork TM, Peterson K, Altaweel MM.   +8 more
europepmc   +1 more source

Viscoelastics Enable Dissection of Anterior Closed Funnels in Proliferative Vitreoretinopathy: A Retrospective Case Series. [PDF]

Case Rep Ophthalmol
Iannetta D, de Smet MD, Valsecchi N, Fontana L, Chhablani J.   +4 more
europepmc   +1 more source

Multi-omics profiling of retinal pigment epithelium reveals enhancer-driven activation of RANK-NFATc1 signaling in traumatic proliferative vitreoretinopathy. [PDF]

Nat Commun
Liao M, Zhu X, Lu Y, Yi X, Hu Y, Zhao Y, Ye Z, Guo X, Liang M, Jin X, Zhang H, Wang X, Zhao Z, Chen Y, Yan H.   +14 more
europepmc   +1 more source

Vitreous Biomarkers for Proliferative Vitreoretinopathy Prognostication in Patients Undergoing Primary Retinal Detachment Repair. [PDF]

Transl Vis Sci Technol
Shahlaee A, Yang D, Chen J, Lamy R, Stewart JM.   +4 more
europepmc   +1 more source

Outcomes after giant peripheral retinotomy and anterior flap retinectomy for rhegmatogenous retinal detachments with advanced proliferative vitreoretinopathy using small gauge vitrectomy. [PDF]

Indian J Ophthalmol
Agarwal A, Menia NK, Markan A, Sallam AB, Habib A, Mansour A, Iovino C, Peiretti E, Demirel S, Tawfiq MA, Hanout M, Gupta V, Ghazi N, Sengupta S.   +13 more
europepmc   +1 more source

Enantiomeric Agonists of the Type 2 Cannabinoid Receptor Reduce Retinal Damage during Proliferative Vitreoretinopathy and Inhibit Hyperactive Microglia <i>In Vitro</i>. [PDF]

ACS Pharmacol Transl Sci
Young AP, Szczesniak AM, Hsu K, Kelly MEM, Denovan-Wright EM.   +4 more
europepmc   +1 more source

Mechanisms in proliferative vitreoretinopathy [PDF]

Ophthalmology Clinics of North America, 2002
The wound-healing paradigm for proliferative vitreoretinopathy has provided numerous avenues for investigation into the pathobiology of the process. The emerging picture is a complex interaction of cytokines, matrix proteins, and metalloproteinases influencing cell behavior and resulting in the formation of undesirable periretinal membranes.
Jorge G. Arroyo, Ivana K. Kim
openaire   +2 more sources